Casi Pharmaceuticals Inc Expected To Post A Loss Of 7 Cents A Share: Earnings Preview

CASI Pharmaceuticals

10/08/2021 15:33

* CASI Pharmaceuticals Inc  CASI.OQ   CASI.O  is expected
to show a rise in quarterly revenue when it reports results on
August 12. 
* The Rockville, Maryland-based company is expected to report 
 a 125.4% increase in revenue to $6.019 million from $2.67
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for CASI Pharmaceuticals
Inc is for a loss of 7 cents per share. For the same quarter
last year, the company reported a loss of 7 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for CASI
Pharmaceuticals Inc is $4​, about 70.5% above​ its last closing
price of $1.18. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.06       -0.06      -0.11     Missed  -83.3
 Dec. 31 2020              -0.07      -0.12     Missed  -71.4
 Sep. 30 2020  -0.06       -0.05      -0.14     Missed  -154.5
                                                        ​
 Jun. 30 2020  -0.08       -0.08      -0.07     Beat    12.5
 Mar.          ​           -0.11      -0.09     Beat    18.2​
 31​ 2020​                                              
 Dec. 31 2019              -0.11      -0.12     Missed  -9.1​
 Sep. 30 2019  -0.11       -0.11      -0.10     Beat    9.1
 Jun. 30 2019  -0.09       -0.09      -0.16     Missed  -77.8
 This summary was machine generated August 10 at 14:33 GMT.  All
figures in US dollars unless otherwise stated